• Awarded "Shanghai Specialized, Refined, Unique and Innovative SME" status
Kylin Lab is a preclinical CRO company specializing in central nervous system (CNS) diseases, dedicated to offering one stop solutions for CNS drug discovery. With a portfolio of fully-validated cellular and animal disease models, combined with comprehensive research and analytical capabilities, we empower clients to accelerate the development of innovative therapies and reduce clinical trial risks.
Our technical team is highly experienced, familiar with international regulations, and conducts their work based on high-standard experimental platforms. Our core technologies include AI-driven phenotypic screening, humanized stem cells and organoids, electrophysiology, high-throughput electroencephalography (EEG), histology, and molecular biology. Our expertise spans a broad range of areas including Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, spinal muscular atrophy (SMA), pain, stroke,etc.
Since its establishment, we have steadfastly upheld the principle of "Pioneering in R&D, Leading in Technology, Prioritizing Quality, First Customer."To date, we have served over a hundred clients, successfully completed numerous specialized research projects and IND applications, and established a high-quality, robust, and forward-looking efficacy evaluation system.
70 70
+100 100
+100 100
+to enable breakthrough CNS therapies
Advancing More High-Quality Treatments to
Patients
Prioritizing Quality, First Customer